A new initiative called BEACON is bringing together scattered benchmarking efforts across biomedical research to tackle one of modern science's biggest problems: the inability to reproduce published findings. The Benchmarking, Evaluation, and Assessment Consortium for Science (BEACON) addresses a troubling reality where up to 50% of claims in fields like preclinical research may be inaccurate, inflated, under-specified, or non-replicable.

Why Is Reproducibility Such a Big Problem in Science?

The crisis is well-documented. In psychology, researchers attempting to replicate 100 statistically significant findings from 2008 journal articles found that only 36% achieved significance in the same direction when tested again. In preclinical oncology, Amgen researchers could confirm the findings of only 11% of 53 landmark cancer papers. The Reproducibility Project: Cancer Biology reported a 46% success rate when attempting to replicate 112 findings.

The problem isn't necessarily dishonest researchers, but rather structural incentives that reward exciting claims over reliable ones. Publishing systems prioritize novelty and breakthrough discoveries, which naturally encourages researchers to overclaim results. This creates a cascade of questionable practices that undermine scientific integrity.

Gustavo Stolovitzky, a computational biologist and founding director of NYU Langone's Bio-DaSH, explained the core issue: "Fear of being wrong should be one of the most important scientific emotions; not fear that paralyzes inquiry, but fear that disciplines it. Fear that forces us to ask: Have I fooled myself? Would this result survive a different dataset, a different laboratory, a different analyst, a different year?"

What Practices Contribute to Non-Reproducible Research?

Multiple factors push research toward questionable outcomes. In traditional biomedical research, these include:

• Methodological Issues: Small datasets, flexible analysis pipelines, selective reporting of results, and insufficient blinding of researchers to treatment conditions.
• Statistical Problems: P-hacking (testing multiple hypotheses until finding statistical significance), hypothesizing after results are known (HARKing), and the "file drawer" effect where negative results remain unpublished.
• Technical Variability: Reagent variability and inconsistent experimental conditions across different laboratories.
• Machine Learning Specific Issues: Data leakage, inadequate separation of training and test datasets, overfitting to training data, and test sets that don't represent the target population.

Perhaps most troubling, non-replicable research doesn't simply disappear from the scientific record. A recent study found that papers failing to replicate in major replication projects were cited more often than papers that did replicate. This means the scientific literature actively amplifies the most compelling errors rather than self-correcting.

How Does Benchmarking Combat the Reproducibility Crisis?

Benchmarking works by creating standardized, transparent evaluation frameworks that allow researchers to test their methods against common problems with known answers. The approach was pioneered by the Critical Assessment of protein Structure Prediction (CASP), founded in response to exaggerated claims in protein-structure prediction research. CASP's key innovation was posing hard problems fairly: every two years, researchers predicted protein structures not yet made public, and independent assessors compared predictions against experimental results.

This framework transformed the field. For years, CASP allowed protein-structure prediction to measure genuine progress, showing where advances were real versus incremental. When AlphaFold, the Nobel Prize-winning deep learning system, entered CASP's arena under the same blind assessment standards, its breakthrough achievement could be recognized precisely because the field had built a common measurement system decades earlier.

Stolovitzky founded the Dialogue for Reverse Engineering Assessment and Methods (DREAM) Challenges in 2006, applying CASP's principles to biomedical modeling. The approach is straightforward: pose a problem, withhold the answer, invite the community to solve it, then score submissions objectively against the known answer and publish lessons learned. The goal isn't to crown winners but to discipline claims and validate which methods actually generalize beyond their original datasets.

How to Implement Benchmarking Across Siloed Research Efforts

BEACON's mission is to bridge fragmented benchmarking initiatives that currently operate in isolation. The initiative works by:

• Uniting Siloed Efforts: Bringing together separate benchmarking projects across different biomedical research areas so they can share methodologies, datasets, and evaluation standards rather than each operating independently.
• Enabling Synergistic Validation: Allowing validation activities to work together, creating a more comprehensive picture of which methods and findings actually hold up across different contexts and datasets.
• Building Bridges Between Communities: Fostering communication between researchers in different fields so successful benchmarking approaches from one area can be adapted and applied to others.

The core insight is that benchmarking validates scientific claims, leading to increased scientific rigor and reproducibility. By creating common evaluative languages and fair testing frameworks, the scientific community can distinguish genuine progress from inflated claims before they become entrenched in the literature.

This approach addresses a fundamental problem in how modern science operates. The publishing landscape rewards exciting claims and new discoveries, which can lead to overhype and questionable research practices. Benchmarking provides a counterbalance by requiring researchers to test their methods against standardized problems with transparent evaluation criteria. The result is a more reliable scientific record that actually self-corrects rather than amplifying errors.